152 related articles for article (PubMed ID: 38425118)
1. Diabetes and its Complications: Role of Luteolin, A Wonder Chemical from the Natural Source.
Pradhan G; Kulkarni YA
Curr Diabetes Rev; 2024 Feb; ():. PubMed ID: 38425118
[TBL] [Abstract][Full Text] [Related]
2. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
3. Immunopharmacological Activities of Luteolin in Chronic Diseases.
Huang L; Kim MY; Cho JY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768462
[TBL] [Abstract][Full Text] [Related]
4. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
5. Natural Flavonoids as Potential Therapeutics in the Management of Diabetic Wound: A Review.
Chanu NR; Gogoi P; Barbhuiya PA; Dutta PP; Pathak MP; Sen S
Curr Top Med Chem; 2023; 23(8):690-710. PubMed ID: 37114791
[TBL] [Abstract][Full Text] [Related]
6. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
Nabavi SF; Braidy N; Gortzi O; Sobarzo-Sanchez E; Daglia M; Skalicka-Woźniak K; Nabavi SM
Brain Res Bull; 2015 Oct; 119(Pt A):1-11. PubMed ID: 26361743
[TBL] [Abstract][Full Text] [Related]
7. Nanoformulations of flavonoids for diabetes and microvascular diabetic complications.
Agarawal K; Anant Kulkarni Y; Wairkar S
Drug Deliv Transl Res; 2023 Jan; 13(1):18-36. PubMed ID: 35637334
[TBL] [Abstract][Full Text] [Related]
8. Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review.
Muruganathan N; Dhanapal AR; Baskar V; Muthuramalingam P; Selvaraj D; Aara H; Shiek Abdullah MZ; Sivanesan I
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422285
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity of Luteolin Against Ehrlich Solid Carcinoma in Rats via Blocking Wnt/β-Catenin/SMAD4 Pathway.
Aljohani H; Khodier AE; Al-Gayyar MM
Cureus; 2023 May; 15(5):e39789. PubMed ID: 37265908
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of flavonoids and carotenoids against diabetic complications-A review of
Jin Y; Arroo R
Front Nutr; 2023; 10():1020950. PubMed ID: 37032781
[TBL] [Abstract][Full Text] [Related]
11. Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy.
Sood A; Kumar B; Singh SK; Prashar P; Gautam A; Gulati M; Pandey NK; Melkani I; Awasthi A; Saraf SA; Vidari G; Ozdemir M; Hussain FHS; Anwar ET; Ameen MSM; Gupta S; Porwal O
Curr Pharm Des; 2020; 26(42):5468-5487. PubMed ID: 32851955
[TBL] [Abstract][Full Text] [Related]
12. Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review.
Egbuna C; Awuchi CG; Kushwaha G; Rudrapal M; Patrick-Iwuanyanwu KC; Singh O; Odoh UE; Khan J; Jeevanandam J; Kumarasamy S; Chukwube VO; Narayanan M; Palai S; Găman MA; Uche CZ; Ogaji DS; Ezeofor NJ; Mtewa AG; Patrick-Iwuanyanwu CC; Kesh SS; Shivamallu C; Saravanan K; Tijjani H; Akram M; Ifemeje JC; Olisah MC; Chikwendu CJ
Curr Top Med Chem; 2021; 21(12):1067-1095. PubMed ID: 33966619
[TBL] [Abstract][Full Text] [Related]
13. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
14. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
[TBL] [Abstract][Full Text] [Related]
15. Luteolin attenuates diabetes-associated cognitive decline in rats.
Liu Y; Tian X; Gou L; Sun L; Ling X; Yin X
Brain Res Bull; 2013 May; 94():23-9. PubMed ID: 23415807
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Anti-Nociceptive and Anti-Inflammatory Effect of Luteolin in Mice.
Fan X; Du K; Li N; Zheng Z; Qin Y; Liu J; Sun R; Su Y
J Environ Pathol Toxicol Oncol; 2018; 37(4):351-364. PubMed ID: 30806241
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic effect of flavonoid from
Al-Masri AA; Ameen F; Davella R; Mamidala E
Biotechnol Genet Eng Rev; 2023 May; ():1-16. PubMed ID: 37191034
[TBL] [Abstract][Full Text] [Related]
18. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.
Choi JS; Islam MN; Ali MY; Kim YM; Park HJ; Sohn HS; Jung HA
Arch Pharm Res; 2014 Oct; 37(10):1354-63. PubMed ID: 24988985
[TBL] [Abstract][Full Text] [Related]
19. Tannins and vascular complications of Diabetes: An update.
Laddha AP; Kulkarni YA
Phytomedicine; 2019 Mar; 56():229-245. PubMed ID: 30668344
[TBL] [Abstract][Full Text] [Related]
20. Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences.
Li M; Li Q; Zhao Q; Zhang J; Lin J
Int J Clin Exp Pathol; 2015; 8(9):10112-20. PubMed ID: 26617718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
